Skip to main content
. 2019 Oct 22;3(20):3080–3091. doi: 10.1182/bloodadvances.2019000250

Figure 5.

Figure 5.

Peripheral leukocyte profile, and intratumoral macrophages and cell proliferation index. (A) Leukocyte profile from complete blood counts at 80 days of age in healthy and MMTV-PyMT mice. (B) Representative images of tumor-infiltrating macrophages on histopathology at the time of euthanasia (complete palpable tumor volume of 2 cm3). Macrophages were visualized with an antibody directed against F4/80, the murine homolog of epidermal growth factor–like module-containing mucin-like hormone receptor-like 1 (green). Nuclei were visualized with Hoechst 33342 (blue). Scale bars, 50 µm. (C) Percentage of F4/80-positive area in the field of view in tumors from untreated (n = 6) and THPO-ASO–treated (n = 6) mice. A 2-tailed, unpaired Student t test was used for comparison of means. *P < .05; **P < .01; ***P < .001. (D) Representative images of proliferating cells in tumors. Proliferating cells were identified by Ki-67, an antibody directed against the MKI67 proliferation-related antigen (green). Nuclei were visualized with Hoechst 33342 (blue). Scale bars, 50 µm. (E) Number of Ki-67–positive (S-phase) cells in magnification field in samples from untreated (n = 6) and THPO-ASO–treated (n = 6) mice. Fifteen fields of view per tumor were analyzed for quantification. Every breast tumor was evaluated for each mouse. A 2-tailed, unpaired Student t test was used for comparison of means. *P < .05.